Nothing Special   »   [go: up one dir, main page]

Onyiriuka et al., 2004 - Google Patents

Perinatal outcome in patients with pre-eclampsia in Benin City, Nigeria

Onyiriuka et al., 2004

View PDF
Document ID
14448953767704689953
Author
Onyiriuka A
Okolo A
Publication year
Publication venue
Tropical Journal of Obstetrics and Gynaecology

External Links

Snippet

Objective: To determine the prevalence of pre-eclampsia and examine its influence on perinatal outcome among Nigerian women. Methods: Among 3780 deliveries over a two- and-half year period, 212 singleton infants were born after preeclamptic pregnancies. We …
Continue reading at www.ajol.info (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4343—Pregnancy and labour monitoring, e.g. for labour onset detection
    • A61B5/435—Assessing cervix alteration or dilation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024—Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02411—Detecting, measuring or recording pulse rate or heart rate of foetuses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0402—Electrocardiography, i.e. ECG
    • A61B5/0444—Foetal cardiography
    • A61B5/0448—Electrodes specially adapted therefor, e.g. scalp electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Similar Documents

Publication Publication Date Title
Kissinger et al. Trauma in pregnancy: predicting pregnancy outcome
Wolfe et al. The clinical utility of maternal body mass index in pregnancy
Collins et al. Seventy-one quadruplet pregnancies: management and outcome
Onyiriuka et al. Perinatal outcome in patients with pre-eclampsia in Benin City, Nigeria
McCowan et al. Umbilical artery Doppler blood flow studies in the preterm, small for gestational age fetus
MIMOUNI et al. High spontaneous premature labor rate in insulin-dependent diabetic pregnant women: an association with poor glycemic control and urogenital infection
Gabbe et al. Lecithin/sphingomyelin ratio in pregnancies complicated by diabetes mellitus
Wankaew et al. Neonatal morbidity and mortality for repeated cesarean section vs. normal vaginal delivery to uncomplicated term pregnancies at Srinagarind Hospital
Leeman et al. Isolated oligohydramnios at term: is induction indicated
Roussis et al. Pre term premature rupture of membranes: detection of infection
Whittle et al. Estriol in pregnancy: VI. Experience with unconjugated plasma estriol assays and antepartum fetal heart rate testing in diabetic pregnancies
Johnson et al. Maternal serum a-fetoprotein in twin pregnancy
Krantz et al. Epidemiological analysis of the increased risk of disturbed neonatal respiratory adaptation after caesarean section
Skouteli et al. Predictors for survival and normal neurodevelopmental outcome of infants weighing less than 1001 grams at birth
Pajntar et al. Maternal and neonatal outcome related to delivery time following premature rupture of membranes
Fraser The fate of the pregnant diabetic in a developing country: Kenya
Xiao et al. Monitoring of pregnancy-induced hypertension syndrome combined with ultrasound monitoring in early pregnancy to prevent chronic hypertension with preeclampsia
Mola et al. Poor weight gain in late third trimester: a predictor of poor perinatal outcome for term deliveries?
Ogunlaja et al. Correlation between placenta and umbilical cord morphplogy and perinatal outcome in singleton deliveries at term in a Nigerian tertiary health Centre
Azzam et al. Effect of Gestational Diabetes mellitus Health Education Module on Pregnancy Outcomes
RU2251976C2 (en) Method for evaluating fetal state and predicting the state in neonatals in case of maternal diabetes mellitus according to circulation values during dopplerometric survey
Abd El Hameed et al. Association between vitamin D deficiency and preterm: A case control study
HAUKKAMAA et al. Screening, management, and outcome of pregnancy in diabetic mothers
lanniruberto et al. Determination of fetal maturity and of development of the fetal lungs by means of combined methods
Celik et al. Does Fetal Fibronectin Predict the Delivery Route in Nulliparous Women at Postterm Induced by Dinoprostone?